Trial
NCT00346879
Study to Determine Effective Dosing of Fondaparinux in Obese Persons
Phase IWITHDRAWNOPERATIONALConfidence: HIGH
Sponsor
Indiana University
Collaborators
American Society for Bariatric Surgery
Condition
Morbid Obesity
Intervention
fondaparinux
Why stopped
Funding withdrawn; study closed due to lack of accrual.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2016-02-23